West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and welcome to the West Pharmaceutical Services Q2 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during that session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Mr. John Sweeney, Vice President of Investor Relations. Please go ahead, sir. Good morning, and welcome to West's second quarter 2026 earnings conference call, which is being webcast live today. With me on the call are Eric Green, our CEO, Chair of the Board, and Bob McMahon, CFO. Earlier today, we issued our second quarter financial results. A copy of the press release along with today's slide presentation containing supplemental information for your reference has been posted in the investor section of the company's website at investor.westpharma.com. Later today, a replay of the webcast will also be available in the investor section of our website. Before we begin, we'd like to remind you that statements made by management during this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. Please refer to the accompanying safe harbor statement currently being displayed on the screen and in today's press release. In addition to other disclosures made by the companies such as our 10-K and 10-Q regarding the risks to which the company is subject. During the call, management will also report on certain non-GAAP financial measures, including or...